If asked what the two major buzzwords of 2026 were, I’d immediately say artificial intelligence and peptides. One Irish company is bringing both of these together.
It had been since high school that I’d donned a white coat and looked at cells under a microscope. But at Nuritas’s labs in the heart of Dublin, Ireland, I did just that to learn more about the intersection of AI and peptides.
Nuritas, a Dublin-based biotechnology company, brings together AI models, clinically proven peptide ingredients and cutting-edge science to accelerate the discovery of peptides that can be used for products that boost human health. Founded in 2014 by Nora…
Read the full article at CNET.COM













